FDA Approved: RETISERT — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for RETISERT (fluocinolone acetonide) by Bausch & Lomb Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noninfectious Uveitis Affecting the Posterior Segment
• Uveitis

Drugs mentioned

• Retisert (fluocinolone acetonide)

Snippet

SUPPL AP for RETISERT (FLUOCINOLONE ACETONIDE)